(PharmaNewsWire.Com, October 09, 2018 ) Global C-Reactive Protein Testing Market Segmented by Application, High Adoption Rate of New Technologies, And Geography - Growth, Trends, And Forecast (2018 - 2023)
The global C-reactive protein (CRP) testing market is expected to register a CAGR of nearly 1.5% during the forecast period of 2018 - 2023. C-reactive protein tests are blood tests, which measure the level of C-reactive protein and estimates if the person is suffering from heart attacks or strokes. This market is driven by the high research and development activities and rising burden of chronic and inflammatory diseases, globally. Based on the geographical regions, North America is a highly profitable region for many companies due to the well-established healthcare infrastructure, high adoption rate of new technologies in testing devices and increasing research and development activities, which is expected to maintain its largest share in this market for the estimated period. Increasing Prevalence of Inflammatory Disorders C-reactive protein is one of the common test parameters used to assess, diagnose, and prognose inflammatory diseases in clinical practice. The concomitant occurrence of multiple stimuli of inflammation and influence of factors other than inflammation like smoking, obesity, and physical stress, reduce the specificity of CRP. A regular standardization of measurement techniques and reporting improve the utility of CRP in routine clinical practice. CRP has multiple applications in vitro and in vivo development of potential new compounds for inflammatory diseases. Thus, in the forecast period, the rising prevalence of inflammatory disorders plays a vital role in driving this market. Other potential factors driving this market are increasing global incidence of endometriosis in women, the rise in funding toward the technological advancement in testing devices, as well as, the rise in the adoption of point of care devices. Get Sample PDF of Global Vascular Access Devices Market Report @ https://www.absolutereports.com/enquiry/request-sample/13104850 Major players: ABAXIS, ABBOTT, DANAHER, HOFFMANN-LA ROCHE LTD., LABORATORY CORPORATION OF AMERICA HOLDINGS, MERCK KGAA, QUEST DIAGNOSTICS, RANDOX LABORATORIES LTD., SIEMENS HEALTHINEERS, AND THERMO FISHER SCIENTIFIC, INC, amongst others. Lack of Public Awareness for CRP Tests The lack of public awareness regarding CRP testing is one of the primary hinderances for the C-reactive testing market. According to a published article of 2016 in Journal of Medicine, Radiology, Pathology & Surgery, in emerging countries such as India, more than 50% of population suffering from diabetes are unaware of the blood tests including CRP tests, for the early diagnosis of diabetes. This also includes the lack of awareness for these tests among clinicians and physicians along with a poor confidence in the usefulness of these tests especially in the emerging markets such as South Asian and African countries. Another factor impeding this market is the availability of alternative treatments with higher accuracy in hospitals or clinical settings. The healthcare professionals have preference over other blood tests such as erythrocyte sedimentation rate (ESR) tests when compared to C-reactive protein testing, which impedes the growth of this market.
Price of Report: $4250 (Single User Licence) Purchase a copy of this Report @ https://www.absolutereports.com/purchase/13104850 By Application Diabetes Rheumatoid Arthritis Cardiovascular Diseases Inflammatory Bowel Disease Cancer And Others.. Have any Query about this report @ https://www.absolutereports.com/enquiry/pre-order-enquiry/13104850 Key Developments in the Market January, 2018 - Meso Scale Diagnostic Llc, received 510 (k) clearance from the US FDA for its conventional C-reactive protein assay for in vitro diagnostic use in the United States. Reasons to Purchase the Report Current and future of the global C-reactive protein testing market outlook in the developed and emerging markets. Analysis of various perspectives of the market with the help of Porters Five Forces Analysis. The segment that is expected to dominate the market. Regions that are expected to witness the fastest growth during the forecast period. Identify the latest developments, market shares, and strategies employed by the major market players.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
